The allocations are scheduled to begin next month, with initial awards totaling $885, of which $500 million will go to what the CDC calls “strike teams” that will focus on nursing homes and other long-term care facilities.
he Biden administration unveiled a $2.1 billion package on September 17, 2021, to improve infection prevention and control measures against COVID-19 and other emerging infectious diseases as part of the $1.9 trillion American Rescue Plan. Rochelle Walensky, MD, MPH, director of the CDC, said in a news release that the “funding will provide significant resources to our public health departments and health care systems and opportunities to develop innovative strategies to protect every segment of the US population, especially those disproportionately affected by the pandemic, at a time that they are hit hard.”1
Just how much Walensky pushed for this move is unclear, but when she became CDC director earlier this year many infection preventionists took heart because of her extensive background in infection prevention and control. Priya Nori, MD, medical director of the antimicrobial stewardship program at Montefiore Health System, told Infection Control Today® during a Q&A in March that “the infectious disease community in particular is incredibly thrilled about the new CDC director. She is a woman who spent her years researching HIV, who was seeing patients for many years—who knows what it is like to be on the front lines.”2
Over the next 3 years, the CDC plans to issue $1.25 billion of the funding to 64 state, local, and territorial health departments to support the effort. The funding will go to about 6000 hospitals, 15,400 nursing homes and other LTCFs, 7900 dialysis clinics, and 4700 ambulatory surgery centers. The allocations total $885 million, of which $500 million will go to what the CDC calls “strike teams” that will focus on LTCFs. The CDC says the strike teams “will allow state and other jurisdictional health departments to staff, train, and deploy strike teams to assist skilled nursing facilities, nursing homes, and other long-term care facilities with known or suspected COVID-19 outbreaks. The strike teams will allow jurisdictions to provide surge capacity to facilities for clinical services; address staffing shortages at facilities; and strengthen infection prevention and control activities to prevent, detect, and contain outbreaks, including support for COVID-19 vaccine boosters.”
In addition, the funding is meant to:
References:
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
“A Marathon and a Sprint”: Passing Surgical Smoke Legislation
March 9th 2024At the AORN’s International Surgical Conference & Expo 2024, a presentation on surgical smoke drew applause and strong emotion about the continuing fight for legislation on removing surgical smoke from operating rooms. Infection Control Today was there to tell you what happened.
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.